Semaglutide, the active ingredient in the diabetes and weight loss drugs Ozempic and Wegovy, could lower the risk for ...

Semaglutide medications — such as Ozempic, the popular diabetes medication — have been linked to a reduced risk of ...

Researchers have found that semaglutide may lower the risk of Alzheimer's disease in people with type 2 diabetes (T2D).

Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking ...

People over 50 who can stand on one leg for 30 seconds are aging gracefully, particularly if it's not their strong leg, a new ...

Semaglutide, found in Novo Nordisk's Ozempic, may reduce Alzheimer's risk in type 2 diabetes patients, per new research. FDA ...

Add Alzheimer's disease to the list of conditions that might benefit from the revolutionary diabetes drug Ozempic, a new ...

According to a recent study, certain classes of weight loss drugs — including Ozempic — may have positive effects on the ...

A new study is adding to evidence that GLP-1 drugs such as Novo Nordisk's semaglutide and Eli Lilly's tirzepatide could also ...

A common diabetes and weight-loss drug may also reduce the risk of Alzheimer’s disease, according to a new study. American ...

People with Type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer's compared ...